Editas Medicine, Inc. Quarterly Current Ratio in % from Q3 2016 to Q3 2024

Taxonomy & unit: ratio: %
Description: The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary: Editas Medicine, Inc. quarterly Current Ratio history and growth rate from Q3 2016 to Q3 2024.
Editas Medicine, Inc. Current Ratio for the quarter ending September 30, 2024 was 436 %, a 32.2% decline year-over-year.

Current Ratio, Quarterly (%)

Current Ratio, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date
Q3 2024	436	-207	-32.2%	Sep 30, 2024
Q2 2024	492	-232	-32%	Jun 30, 2024
Q1 2024	595	-205	-25.6%	Mar 31, 2024
Q4 2023	627	-366	-36.8%	Dec 31, 2023
Q3 2023	643	-525	-44.9%	Sep 30, 2023
Q2 2023	724	-468	-39.3%	Jun 30, 2023
Q1 2023	801	-292	-26.7%	Mar 31, 2023
Q4 2022	993	-26.4	-2.59%	Dec 31, 2022
Q3 2022	1.17K	+233	+24.9%	Sep 30, 2022
Q2 2022	1.19K	+296	+33.1%	Jun 30, 2022
Q1 2022	1.09K	+208	+23.5%	Mar 31, 2022
Q4 2021	1.02K	+236	+30%	Dec 31, 2021
Q3 2021	935	+138	+17.3%	Sep 30, 2021
Q2 2021	895	+198	+28.4%	Jun 30, 2021
Q1 2021	884	+306	+53%	Mar 31, 2021
Q4 2020	784	+172	+28%	Dec 31, 2020
Q3 2020	797	+157	+24.5%	Sep 30, 2020
Q2 2020	697	-92.6	-11.7%	Jun 30, 2020
Q1 2020	578	-534	-48%	Mar 31, 2020
Q4 2019	613	-608	-49.8%	Dec 31, 2019
Q3 2019	640	-537	-45.6%	Sep 30, 2019
Q2 2019	790	-317	-28.7%	Jun 30, 2019
Q1 2019	1.11K	+206	+22.8%	Mar 31, 2019
Q4 2018	1.22K	+426	+53.7%	Dec 31, 2018
Q3 2018	1.18K	+454	+62.8%	Sep 30, 2018
Q2 2018	1.11K	+371	+50.5%	Jun 30, 2018
Q1 2018	906	+34.6	+3.97%	Mar 31, 2018
Q4 2017	794	-398	-33.4%	Dec 31, 2017
Q3 2017	723	-1.07K	-59.8%	Sep 30, 2017
Q2 2017	735			Jun 30, 2017
Q1 2017	871			Mar 31, 2017
Q4 2016	1.19K			Dec 31, 2016
Q3 2016	1.8K			Sep 30, 2016

* An asterisk sign (*) next to the value indicates that the value is likely invalid.